Develop new medical strategies for the prevention, diagnosis, treatment, and cure of human diseases, injuries, and conditions through human stem cells.
The Maryland Stem Cell Research Fund (MSCRF) Manufacturing Assistance Program targets Maryland-based stem cell companies with the goal of advancing the Good Manufacturing Practice (GMP) production of cell therapy products within the state. This initiative is designed to tackle one of the critical challenges in the cell therapy sector: the manufacturing of cell-based products. The program offers initial resources to help companies either build or acquire necessary manufacturing infrastructure, such as modular manufacturing facilities, prefabricated clean rooms, and closed systems, fostering a timely and cost-effective manufacturing process that aligns with market needs. Additionally, it aims to support and retain an advanced manufacturing workforce in Maryland, underpinning the broader objective of accelerating the development of new medical therapies and enhancing our understanding of human diseases, injuries, and conditions through stem cell research.